(47) found that FGF21 inhibited oxidative stress and lipid accumulation through the AMPK/AKT/Nrf2 pathway to improve cardiac function in T2DM mice, which provides a new target for DCM intervention. The gene discussed is FGF21; the disease is familial dilated cardiomyopathy.